U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Ectopic posterior pituitary

MedGen UID:
481201
Concept ID:
C3279571
Anatomical Abnormality; Finding
Synonym: Ectopic posterior pituitary lobe
 
HPO: HP:0011755

Definition

An abnormal anatomical location of the posterior lobe of the hypophysis, also known as the neurohypophysis. The posterior pituitary is normally present in the dorsal portion of the sella turcica, but when ectopic is usually near the median eminence. This defect is likely to be due to abnormal migration during embryogenesis. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Ectopic posterior pituitary

Conditions with this feature

Craniosynostosis 4
MedGen UID:
322167
Concept ID:
C1833340
Disease or Syndrome
Craniosynostosis (CRS) is a primary abnormality of skull growth involving premature fusion of the cranial sutures such that the growth velocity of the skull often cannot match that of the developing brain. This produces skull deformity and, in some cases, raises intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability (summary by Fitzpatrick, 2013). Craniosynostosis-4 (CRS4) includes lambdoid, sagittal, metopic, coronal, and multisuture forms. For a discussion of genetic heterogeneity of craniosynostosis, see CRS1 (123100).
Syndromic microphthalmia type 5
MedGen UID:
350491
Concept ID:
C1864690
Disease or Syndrome
The association of a range of ocular anomalies (anophthalmia, microphthalmia and retinal abnormalities) with variable developmental delay and central nervous system malformations. Less than 20 cases have been reported in the literature so far. The clinical picture is highly variable, even between affected members of the same family. Severe developmental delay was noted in some patients, whilst others showed normal cognitive development. Pituitary dysfunction, leading to growth hormone deficiency and short stature, or combined pituitary hormone deficiency, has also been reported. The syndrome is caused by heterozygous mutations in the OTX2 gene (14q22.3).
Ulnar-mammary syndrome
MedGen UID:
357886
Concept ID:
C1866994
Disease or Syndrome
Ulnar-mammary syndrome (UMS) is an autosomal dominant disorder characterized by posterior limb deficiencies or duplications, apocrine/mammary gland hypoplasia and/or dysfunction, abnormal dentition, delayed puberty in males, and genital anomalies (Bamshad et al., 1996).
Pituitary hormone deficiency, combined, 6
MedGen UID:
462790
Concept ID:
C3151440
Disease or Syndrome
Any combined pituitary hormone deficiencies, genetic form in which the cause of the disease is a mutation in the OTX2 gene.
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
MedGen UID:
862916
Concept ID:
C4014479
Disease or Syndrome
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome is a rare, genetic developmental defect during embryogenesis disorder characterized primarily by congenital hypopituitarism and/or postaxial polydactyly. It can be associated with short stature, delayed bone age, hypogonadotropic hypogonadism, and/or midline facial defects (e.g. hypotelorism, mild midface hypoplasia, flat nasal bridge, and cleft lip and/or palate). Hypoplastic anterior pituitary and ectopic posterior pituitary lobe are frequent findings on MRI examination.
Joubert syndrome 38
MedGen UID:
1794168
Concept ID:
C5561958
Disease or Syndrome
Joubert syndrome-38 (JBTS38) is characterized by hypotonia, global developmental delay, oculomotor apraxia, and breathing abnormalities, with a 'molar tooth sign' on brain MRI. Patients also exhibit pituitary abnormalities with growth hormone deficiency (Stephen et al., 2017). For a general phenotypic description and discussion of genetic heterogeneity of Joubert syndrome, see JBTS1 (213300).
Pituitary hormone deficiency, combined or isolated, 8
MedGen UID:
1841011
Concept ID:
C5830375
Disease or Syndrome
Combined pituitary hormone deficiency-8 (CPHD8) is an autosomal dominant disorder characterized by deficiency of one or more of the pituitary hormones. Affected individuals have short stature due to growth hormone (GH; 139250) deficiency with variable deficiencies of other pituitary hormones, including TSH (see 188540), ACTH, and LH/FSH (see 118850). Posterior pituitary deficiency leading to central diabetes insipidus is rare (Bashamboo et al., 2017). Many patients are diagnosed with 'pituitary stalk interruption syndrome' (PSIS), which is characterized by a thin or absent pituitary stalk, absent or ectopic posterior pituitary, and hypoplasia of the anterior pituitary demonstrated on brain imaging, although this classic triad may be incomplete. Brauner et al. (2020) noted the complex phenotypic and genetic heterogeneity of PSIS, and concluded that it is a feature of genetic disorders or syndromes rather than a specific clinical entity. For a discussion of genetic heterogeneity of combined pituitary hormone deficiency, see CPHD1 (613038).
Neurooculorenal syndrome
MedGen UID:
1841013
Concept ID:
C5830377
Disease or Syndrome
Neurooculorenal syndrome (NORS) is an autosomal recessive developmental disorder with highly variable clinical manifestations involving several organ systems. Some affected individuals present in utero with renal agenesis and structural brain abnormalities incompatible with life, whereas others present in infancy with a neurodevelopmental disorder characterized by global developmental delay and dysmorphic facial features that may be associated with congenital anomalies of the kidney and urinary tract (CAKUT). Additional more variable features may include ocular anomalies, most commonly strabismus, congenital heart defects, and pituitary hormone deficiency. Brain imaging usually shows structural midline defects, including dysgenesis of the corpus callosum and hindbrain. There is variation in the severity, manifestations, and expressivity of the phenotype, even within families (Rasmussen et al., 2018; Munch et al., 2022).

Professional guidelines

PubMed

Fang Q, Benedetti AF, Ma Q, Gregory L, Li JZ, Dattani M, Sadeghi-Nejad A, Arnhold IJ, Mendonca BB, Camper SA, Carvalho LR
Clin Endocrinol (Oxf) 2016 Sep;85(3):408-14. Epub 2016 Apr 28 doi: 10.1111/cen.13067. PMID: 27000987Free PMC Article
Ginat DT, Meyers SP
Radiographics 2012 Mar-Apr;32(2):499-516. doi: 10.1148/rg.322105761. PMID: 22411945
Kalina MA, Kalina-Faska B, Gruszczyńska K, Baron J, Małecka-Tendera E
Childs Nerv Syst 2012 Jan;28(1):121-7. Epub 2011 Sep 21 doi: 10.1007/s00381-011-1594-7. PMID: 21935593Free PMC Article

Recent clinical studies

Etiology

Nannette G, Bar C, Diene G, Pienkowski C, Oliver-Petit I, Jouret B, Cartault A, Porquet-Bordes V, Salles JP, Grunenwald S, Edouard T, Molinas C, Tauber M
J Clin Endocrinol Metab 2023 Jan 17;108(2):323-330. doi: 10.1210/clinem/dgac583. PMID: 36201475
Lyra A, de Faria Guimarães D, Meira AS, Peixoto GV, Sousa E Silva T, Longui CA, Kochi C, da Rocha AJ
Arch Endocrinol Metab 2022 Nov 17;66(6):831-836. Epub 2022 Aug 4 doi: 10.20945/2359-3997000000505. PMID: 35929902Free PMC Article
Cerbone M, Dattani MT
Growth Horm IGF Res 2017 Dec;37:19-25. Epub 2017 Oct 19 doi: 10.1016/j.ghir.2017.10.005. PMID: 29107171
Arnhold IJ, França MM, Carvalho LR, Mendonca BB, Jorge AA
J Mol Endocrinol 2015 Jun;54(3):R141-50. Epub 2015 Apr 15 doi: 10.1530/JME-15-0009. PMID: 25878059
Takahashi T, Miki Y, Takahashi JA, Kanagaki M, Yamamoto A, Fushimi Y, Okada T, Haque TL, Hashimoto N, Konishi J, Togashi K
Eur J Radiol 2005 Jul;55(1):84-91. Epub 2004 Dec 7 doi: 10.1016/j.ejrad.2004.10.003. PMID: 15950103

Diagnosis

Diwaker C, Thadani P, Memon SS, Sarathi V, Lila AR, Arya S, Krishnappa B, Karlekar M, Patil VA, Shah N, Bandgar T
Pituitary 2022 Aug;25(4):645-652. Epub 2022 Jun 24 doi: 10.1007/s11102-022-01243-x. PMID: 35749012
Cerbone M, Dattani MT
Growth Horm IGF Res 2017 Dec;37:19-25. Epub 2017 Oct 19 doi: 10.1016/j.ghir.2017.10.005. PMID: 29107171
Di Iorgi N, Morana G, Allegri AE, Napoli F, Gastaldi R, Calcagno A, Patti G, Loche S, Maghnie M
Best Pract Res Clin Endocrinol Metab 2016 Dec;30(6):705-736. Epub 2016 Nov 24 doi: 10.1016/j.beem.2016.11.008. PMID: 27974186
Di Iorgi N, Allegri AE, Napoli F, Bertelli E, Olivieri I, Rossi A, Maghnie M
Clin Endocrinol (Oxf) 2012 Feb;76(2):161-76. doi: 10.1111/j.1365-2265.2011.04238.x. PMID: 21955099
Ferran Kd, Paiva IA, Gilban DL, Resende M, Souza MA, Beserra IC, Guimarães MM
Arq Neuropsiquiatr 2010 Jun;68(3):400-5. doi: 10.1590/s0004-282x2010000300014. PMID: 20602044

Therapy

He H, Li DM
Endocr Metab Immune Disord Drug Targets 2023;23(9):1229-1234. doi: 10.2174/1871530323666230228110650. PMID: 36852803
Lohiya N, Krishna Prasad H, Narayanasamy K, C Vasudevan R, Krishnamoorthy N
Pediatr Endocrinol Diabetes Metab 2021;27(1):19-25. doi: 10.5114/pedm.2020.101807. PMID: 33599432Free PMC Article
Deal C, Hasselmann C, Pfäffle RW, Zimmermann AG, Quigley CA, Child CJ, Shavrikova EP, Cutler GB Jr, Blum WF
Horm Res Paediatr 2013;79(5):283-92. Epub 2013 May 16 doi: 10.1159/000350829. PMID: 23689058
Tsai SL, Laffan E, Lawrence S
Pediatr Radiol 2012 Jul;42(7):799-804. doi: 10.1007/s00247-012-2349-7. PMID: 22763804
Iacovazzo D, Lugli F, Giampietro A
Endocrine 2012 Oct;42(2):449-50. Epub 2012 Jun 26 doi: 10.1007/s12020-012-9730-z. PMID: 22733394

Prognosis

Diwaker C, Thadani P, Memon SS, Sarathi V, Lila AR, Arya S, Krishnappa B, Karlekar M, Patil VA, Shah N, Bandgar T
Pituitary 2022 Aug;25(4):645-652. Epub 2022 Jun 24 doi: 10.1007/s11102-022-01243-x. PMID: 35749012
Zhang W, Qian F, Lu G, Wu Y, Li R, Xia L, Zhao R, Lin Y, Gu M, Chen W
Medicine (Baltimore) 2020 Dec 11;99(50):e23266. doi: 10.1097/MD.0000000000023266. PMID: 33327247Free PMC Article
Cerbone M, Dattani MT
Growth Horm IGF Res 2017 Dec;37:19-25. Epub 2017 Oct 19 doi: 10.1016/j.ghir.2017.10.005. PMID: 29107171
Di Iorgi N, Morana G, Allegri AE, Napoli F, Gastaldi R, Calcagno A, Patti G, Loche S, Maghnie M
Best Pract Res Clin Endocrinol Metab 2016 Dec;30(6):705-736. Epub 2016 Nov 24 doi: 10.1016/j.beem.2016.11.008. PMID: 27974186
Jagtap VS, Acharya SV, Sarathi V, Lila AR, Budyal SR, Kasaliwal R, Sankhe SS, Bandgar TR, Menon PS, Shah NS
Pituitary 2012 Jun;15(2):243-50. doi: 10.1007/s11102-011-0321-4. PMID: 21667124

Clinical prediction guides

Lyra A, de Faria Guimarães D, Meira AS, Peixoto GV, Sousa E Silva T, Longui CA, Kochi C, da Rocha AJ
Arch Endocrinol Metab 2022 Nov 17;66(6):831-836. Epub 2022 Aug 4 doi: 10.20945/2359-3997000000505. PMID: 35929902Free PMC Article
Diwaker C, Thadani P, Memon SS, Sarathi V, Lila AR, Arya S, Krishnappa B, Karlekar M, Patil VA, Shah N, Bandgar T
Pituitary 2022 Aug;25(4):645-652. Epub 2022 Jun 24 doi: 10.1007/s11102-022-01243-x. PMID: 35749012
Voutetakis A
Handb Clin Neurol 2021;181:9-27. doi: 10.1016/B978-0-12-820683-6.00002-6. PMID: 34238482
Lodge EJ, Xekouki P, Silva TS, Kochi C, Longui CA, Faucz FR, Santambrogio A, Mills JL, Pankratz N, Lane J, Sosnowska D, Hodgson T, Patist AL, Francis-West P, Helmbacher F, Stratakis C, Andoniadou CL
JCI Insight 2020 Oct 27;5(23) doi: 10.1172/jci.insight.134310. PMID: 33108146Free PMC Article
Di Iorgi N, Allegri AE, Napoli F, Bertelli E, Olivieri I, Rossi A, Maghnie M
Clin Endocrinol (Oxf) 2012 Feb;76(2):161-76. doi: 10.1111/j.1365-2265.2011.04238.x. PMID: 21955099

Recent systematic reviews

Candela E, La Corte E, Zucchini S, Lefosse M, Toni F, Zucchelli M
Horm Res Paediatr 2023;96(4):349-355. Epub 2022 Aug 24 doi: 10.1159/000526617. PMID: 36001954

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...